Search - tctmd.com

Displaying 961 - 980 of 2314

Sort: Relevancy | Date

Presentation TCT 2017

Topic 1: How Should We Evaluate Technologies in Their Infancy? TAVR, Renal Denervation, BVS, LAA Closure, Mechanical Circulatory Support, and More

Presenter: Robert A. Byrne, Gregg W. Stone, Aaron V. Kaplan

October 30, 2017

Presentation TCT 2017

Does Left Ventricular Hypertrophy Compromise Coronary Flow Reserve and Affect Intervention Choices?

Presenter: Mark C. Bates, Bernard J. Gersh, Justin E. Davies

October 30, 2017

Presentation TCT 2017

When Should Coronary Disease Be Suspected and Worked Up in Hypertension?

Presenter: Mark C. Bates, Bernard J. Gersh, Farrell O. Mendelsohn

October 30, 2017

Presentation TCT 2017

Why Are Hypertension and Coronary Artery Disease So Connected?

Presenter: Mark C. Bates, Bernard J. Gersh, Suzanne Oparil

October 30, 2017

Presentation TCT 2017

Renal Artery Atherosclerosis and Secondary Hypertension: Frequency, Diagnosis, and Treatment

Presenter: Mark C. Bates, Bernard J. Gersh, Michael R. Jaff

October 30, 2017

Presentation TCT 2017

Uncontrolled Hypertension Management Issues: Adherence, Testing, and Difficult Patient Scenarios

Presenter: Sidney C. Smith, Michael A. Weber

October 30, 2017

Presentation TCT 2017

What is the Optimal Therapy for Hypertension?

Presenter: Sidney C. Smith, Michael A. Weber

October 30, 2017

Presentation TCT 2017

Radial Approach and Renal Protection: A MATRIX Trial Analysis

Presenter: Prashant Kaul, Jennifer A. Tremmel, Marco Valgimigli

October 30, 2017

Presentation TCT 2017

Office, Home, or Ambulatory Blood Pressure: How to Measure Blood Pressure in Practice and Clinical Trials

Presenter: Sidney C. Smith, Michael A. Weber, C. Venkata S. Ram

October 30, 2017

Presentation TCT 2017

New U.S. Hypertension Guidelines and Treatment Targets

Presenter: Sidney C. Smith, Michael A. Weber, Sandra J Taler

October 30, 2017

Presentation TCT 2017

Recent Clinical Trials and Nonrandomized Studies That Will Change Your Daily Practice

Presenter: Sidney C. Smith, Michael A. Weber, Vasilios Papademetriou

October 30, 2017

News Conference News TCT 2017

Live From Denver: TCT 2017, Day One

Shelley Wood

October 30, 2017

News Conference News TCT 2017

CULPRIT-SHOCK Disputes Benefit of Immediate Multivessel PCI in Patients With Cardiogenic Shock

Todd Neale

October 30, 2017

News Daily News

Any Stable Troponin T Level Detectable by a High-Sensitivity Assay Signals Higher Death Risk

Todd Neale

October 23, 2017

News Daily News

Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI

Yael L. Maxwell

October 20, 2017

News Daily News

Lower Limb Revascularizations Increasing in PAD Patients on Dialysis

L.A. McKeown

October 18, 2017

Presentation

Comparative Outcomes of US Patients With Advanced Renal Dysfunction Undergoing TAVR

October 17, 2017

News Daily News

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Shelley Wood

October 16, 2017

News Daily News

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Shelley Wood

October 10, 2017

News Daily News

High-Sensitivity Troponin Tests Still Useful in Patients With Renal Dysfunction and Suspected ACS, With Caveats

Yael L. Maxwell

October 06, 2017

Advertisement

Topic 1: How Should We Evaluate Technologies in Their Infancy? TAVR, Renal Denervation, BVS, LAA Closure, Mechanical Circulatory Support, and More

Does Left Ventricular Hypertrophy Compromise Coronary Flow Reserve and Affect Intervention Choices?

When Should Coronary Disease Be Suspected and Worked Up in Hypertension?

Why Are Hypertension and Coronary Artery Disease So Connected?

Renal Artery Atherosclerosis and Secondary Hypertension: Frequency, Diagnosis, and Treatment

Uncontrolled Hypertension Management Issues: Adherence, Testing, and Difficult Patient Scenarios

What is the Optimal Therapy for Hypertension?

Radial Approach and Renal Protection: A MATRIX Trial Analysis

Office, Home, or Ambulatory Blood Pressure: How to Measure Blood Pressure in Practice and Clinical Trials

New U.S. Hypertension Guidelines and Treatment Targets

Recent Clinical Trials and Nonrandomized Studies That Will Change Your Daily Practice

Live From Denver: TCT 2017, Day One

CULPRIT-SHOCK Disputes Benefit of Immediate Multivessel PCI in Patients With Cardiogenic Shock

Any Stable Troponin T Level Detectable by a High-Sensitivity Assay Signals Higher Death Risk

Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI

Lower Limb Revascularizations Increasing in PAD Patients on Dialysis

Comparative Outcomes of US Patients With Advanced Renal Dysfunction Undergoing TAVR

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

High-Sensitivity Troponin Tests Still Useful in Patients With Renal Dysfunction and Suspected ACS, With Caveats

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content